Protein Laboratories Rehovot

Company Overview

Snapshot

Founded in August 2003 by Prof. Arieh Gertler, Protein Laboratories Rehovot operates with 1–10 employees. The company's core activity involves the production of biologically active recombinant proteins, a technology that originated from a technology transfer in August 2003 for the production of biologically active recombinant protein in E. coli.

Business overview

Protein Laboratories Rehovot (PLR) specializes in the production of biologically active recombinant proteins, primarily various cytokines and their soluble receptors, utilizing E. coli. The company manages the entire process from optimizing protein sequences and over-expression to purification of inclusion bodies, refolding into biologically active proteins, and final purification to over 98% homogeneity. PLR serves the Health Tech & Life Sciences sector, with a focus on pharmaceuticals, and targets researchers, academia, and pharmaceutical companies globally and in Israel.

Company Intelligence Q&A

What is the primary focus of Protein Laboratories Rehovot?

Protein Laboratories Rehovot (PLR) focuses on the production of biologically active recombinant proteins, including various cytokines and their soluble receptors, using E. coli.

When was Protein Laboratories Rehovot founded?

Protein Laboratories Rehovot was founded in August 2003.

Who are the founders of Protein Laboratories Rehovot?

Prof. Arieh Gertler is a founder and CEO of Protein Laboratories Rehovot.

What is the operational status of Protein Laboratories Rehovot?

Protein Laboratories Rehovot is currently Non Active, having ceased to operate in December 2025.

What was a key early technology milestone for the company?

In August 2003, Protein Laboratories Rehovot achieved a technology success story with the production of biologically active recombinant protein in E. coli, a development in biotechnology and life sciences.